Effects of Respiratory Muscle Exercises on Glucose Tolerance in Healthy Adults

March 16, 2023 updated by: Swiss Federal Institute of Technology
To evaluate the acute effects of respiratory muscle exercises vs. a control intervention on blood glucose kinetics in healthy adults after an oral glucose tolerance test.

Study Overview

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • ZH
      • Zürich, ZH, Switzerland, 8057
        • Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥18 years
  • Healthy
  • Non-smoking
  • Body mass index (BMI): 18.5 - 29.9 kg∙m-2
  • Normal lung function
  • Willing to adhere to study rules

Exclusion Criteria:

  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Previous enrolment into the current study
  • Intake of medications affecting metabolism, the cardiovascular or the respiratory system, or sleep
  • Acute illness or chronic conditions of the gastrointestinal tract, and health conditions affecting metabolism, the cardiovascular or the respiratory system, or sleep
  • Pregnancy, breastfeeding, or intention to become pregnant during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Respiratory Muscle Exercises
Two respiratory muscle exercises
5 min of hyperpnea at a target intensity of 60-80% MVV 15-30min after ingestion of 75g of glucose
5 min of hyperpnea at a target intensity of 60-70% MVV 15-30min after ingestion of 75g of glucose
No Intervention: Control
The control intervention consists of quiet sitting for 15 min

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak blood glucose concentration
Time Frame: throughout the study, an expected average of 2 weeks per participant
Peak blood glucose concentration will be determined in the three conditions (5min or 15min respiratory muscle exercises or control).
throughout the study, an expected average of 2 weeks per participant
area under the glucose-time curve
Time Frame: throughout the study, an expected average of 2 weeks per participant
Area under the glucose-time curve will be determined in the three conditions (5min or 15min respiratory muscle exercises or control).
throughout the study, an expected average of 2 weeks per participant

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christin M. Spengler, Prof., Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 20, 2020

Primary Completion (Actual)

April 21, 2022

Study Completion (Actual)

April 21, 2022

Study Registration Dates

First Submitted

August 17, 2020

First Submitted That Met QC Criteria

August 19, 2020

First Posted (Actual)

August 20, 2020

Study Record Updates

Last Update Posted (Actual)

March 17, 2023

Last Update Submitted That Met QC Criteria

March 16, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HOGTT_2020

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Aging

Clinical Trials on 5min respiratory muscle exercises

3
Subscribe